Overview
Muscular pseudohypertrophy-hypothyroidism syndrome, also known as Kocher-Debré-Sémélaigne syndrome, is a rare condition characterized by the combination of congenital or acquired hypothyroidism with generalized muscular pseudohypertrophy (enlarged muscles that appear well-developed but are actually weak). This syndrome predominantly affects children and is caused by longstanding, untreated or inadequately treated hypothyroidism. The muscular enlargement gives the child a 'Herculean' or athletic appearance despite significant muscle weakness and stiffness. The condition primarily affects the skeletal muscular system and the endocrine system. Key clinical features include diffuse enlargement of muscles (particularly in the calves, thighs, and arms), muscle stiffness, slowness of movement, muscle weakness, and the classic signs of hypothyroidism such as growth retardation, delayed bone age, fatigue, constipation, dry skin, and intellectual slowing. The muscles may feel firm and rubbery on palpation. Laboratory findings typically reveal elevated thyroid-stimulating hormone (TSH), low thyroid hormone levels (T3 and T4), and often markedly elevated creatine kinase levels reflecting muscle involvement. The condition is generally reversible with appropriate thyroid hormone replacement therapy. Treatment with levothyroxine leads to gradual resolution of the muscular pseudohypertrophy and improvement in muscle strength, along with correction of the hypothyroid state. Early diagnosis and treatment are important to prevent long-term complications including growth failure and neurodevelopmental delay. The prognosis is excellent when thyroid replacement therapy is initiated promptly.
Also known as:
Clinical phenotype terms— hover any for plain English:
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Muscular pseudohypertrophy-hypothyroidism syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Muscular pseudohypertrophy-hypothyroidism syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Muscular pseudohypertrophy-hypothyroidism syndrome.
Community
No community posts yet. Be the first to share your experience with Muscular pseudohypertrophy-hypothyroidism syndrome.
Start the conversation →Latest news about Muscular pseudohypertrophy-hypothyroidism syndrome
No recent news articles for Muscular pseudohypertrophy-hypothyroidism syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Muscular pseudohypertrophy-hypothyroidism syndrome
What is Muscular pseudohypertrophy-hypothyroidism syndrome?
Muscular pseudohypertrophy-hypothyroidism syndrome, also known as Kocher-Debré-Sémélaigne syndrome, is a rare condition characterized by the combination of congenital or acquired hypothyroidism with generalized muscular pseudohypertrophy (enlarged muscles that appear well-developed but are actually weak). This syndrome predominantly affects children and is caused by longstanding, untreated or inadequately treated hypothyroidism. The muscular enlargement gives the child a 'Herculean' or athletic appearance despite significant muscle weakness and stiffness. The condition primarily affects the sk
At what age does Muscular pseudohypertrophy-hypothyroidism syndrome typically begin?
Typical onset of Muscular pseudohypertrophy-hypothyroidism syndrome is childhood. Age of onset can vary across affected individuals.
Which specialists treat Muscular pseudohypertrophy-hypothyroidism syndrome?
1 specialists and care centers treating Muscular pseudohypertrophy-hypothyroidism syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.